New data on the long term benefits of Ocrelizumab for PPMS has recently been published 29 October 2020 on the Lancet Ocrelizumab is currently funded for RRMS in New Zealand…read more
Keep up with the latest researching on COVID-19 as it relates to Multiple Sclerosisread more
Exploring patterns of medicinal cannabis use prior to implementation of the new Medicinal Cannabis Scheme (MCS) in New Zealand.read more
Positive psychological health and self-compassion are important for positive outcomes for people with MS and protect them against poorer outcomes.read more
Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease onsetread more
Research findingsread more
This short guide is a resource to help people with multiple sclerosis (MS) understand how they can keep their brains as healthy as possible and request the highest possible standard…read more
Policy initiative to stimulate debate about advocating a treatment approach in multiple sclerosis that aims to minimize disease activity and maximize lifelong ‘brain health’read more
A team of researchers has published results from a small, five-year study of transplantation of individuals’ own hematopoietic (blood cell-producing) stem cells combined with high-dose immunotherapy in 24 people with…read more
